A Double blind, Randomized, Placebo controlled, Parallel Group, Prospective, Multicentre Clinical Trial for Evaluation of Efficacy and Safety of Fixed Dose Combination of Minoxidil (5%) plus Finasteride (0.1%) Lipid Solution in Comparison with Minoxidil (5%) Lipid Solution and Finasteride (0.1%) Lipid solution in Adult Male Patients with Androgenetic Alopecia - NA

Trial Profile

A Double blind, Randomized, Placebo controlled, Parallel Group, Prospective, Multicentre Clinical Trial for Evaluation of Efficacy and Safety of Fixed Dose Combination of Minoxidil (5%) plus Finasteride (0.1%) Lipid Solution in Comparison with Minoxidil (5%) Lipid Solution and Finasteride (0.1%) Lipid solution in Adult Male Patients with Androgenetic Alopecia - NA

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Finasteride/minoxidil (Primary) ; Finasteride; Minoxidil
  • Indications Alopecia
  • Focus Therapeutic Use
  • Sponsors Intas Pharmaceuticals
  • Most Recent Events

    • 25 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top